Excelsior Biopharma Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Excelsior Biopharma Inc

Watchlist Manager

Watchlist

Price: 23.85 TWD Market Closed

Market Cap: NT$1.1B

E	Excelsior Biopharma Inc TPEX:6496	TW

Profitability Summary

Excelsior Biopharma Inc's profitability score is 15/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

39%

Sustainable 3Y Average Gross Margin

42%

Gross Margin is Increasing

38% > 39%

Negative Operating Margin

-21%

Negative 3Y Average Operating Margin

-14%

Declining Operating Margin

-12% > -21%

Negative Net Margin

-22%

Negative 3Y Average Net Margin

-15%

Declining Net Margin

-13% > -22%

Negative Free Cash Flow Margin

-17%

Negative 3Y Average Free Cash Flow Margin

-27%

Declining Free Cash Flow Margin

-16% > -17%

Negative ROE

-26%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-12%

Declining ROIC

-13% > -18%

View All

Hide

Collapse

15 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

39%

Sustainable 3Y Average Gross Margin

42%

Gross Margin is Increasing

38% > 39%

Negative Operating Margin

-21%

Negative 3Y Average Operating Margin

-14%

Declining Operating Margin

-12% > -21%